Allotment of scrip shares to Directors

RNS Number : 7299R

The MedicX Fund Limited

01 July 2015

 

Press Release

For immediate release                                                                                    

1 July 2015

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Allotment of scrip shares to Directors of the Company

Members of the Company's Board of Directors elected to participate in the Company's scrip dividend scheme in respect of the June 2015 interim dividend for the quarter ended 31 March 2015, and accordingly acquired ordinary shares of no par value in the Company (the "Shares") as disclosed in the table below. The Shares were sold out of treasury by the Company at the previously advised scrip calculation price of 82.65 pence per share.

	Shares Acquired	Total Shares Held	Percentage Holding
David Staples (Chairman)	1,475	84,155	0.023%
Shelagh Mason	493	28,163	0.008%
John Hearle	481	27,484	0.008%

The Shares were acquired on 30 June 2015 and rank pari passu with the Company's existing ordinary shares.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

End

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman

Octopus Healthcare Group                                               [phone]

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Buchanan                                                                      [phone]

Charles Ryland/Victoria Watkins

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "MedicX Fund", "the Fund" or "the Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 143 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the Octopus Healthcare Group. The Octopus Healthcare Group is a specialist investor, developer and manager of healthcare properties with 37 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCDMGFVKGGGKZM